
Top news of the week from Pharmacy Times®.

Pharmacists can play a role in the drug reimbursement process for oncology products, which are among the most expensive of all pharmaceuticals.

Health executives and professionals are encouraged to take the short survey to provide Managed Healthcare Executive® with the latest data in the pharmacy industry.

FDA officials based their approval on the review of data and evidence that demonstrated a close similarity between pegfilgrastim-apgf and its reference product.

The CDC’s update to the Immunization Schedule highlights the new best practices and the efficacy and safety of crucial vaccines for children, according to a session at the virtual National Association of Pediatric Nurse Practitioners 2020 Annual Meeting.

This Tip of the Week examines a case where a pharmacist actually sued his state’s Board of Pharmacy.

Although COPD often develops as a result of smoking, researchers have long puzzled over why nearly one-third of cases occur in people who never smoked.

Today, we’re celebrating Kyle Tadaki, BS Pharm, BCPS, BCPPS, RPh, clinical pharmacy manager at the Kapi’olani Medical Center for Women and Children in Honolulu, Hawaii.

As Alzheimer disease research evolves beyond targeting a single pathology, interventions should coordinate disease stage with pathology and the patient’s presenting characteristics.

According to a recent study, patients with type 2 diabetes mellitus (T2D), but not prediabetes, demonstrated poorer cognitive performance 3 to 6 months after a stroke.

Researchers funded by the National Institutes of Health (NIH) have launched an effort to evaluate drugs prescribed to treat coronavirus disease 2019 (COVID-19) in infants, children, and adolescents across the United States.

A new study conducted by researchers at Bar-Ilan University and the University of Haifa has linked coronavirus disease 2019 (COVID-19)-based loneliness in older adults with elevated psychiatric symptoms of anxiety, depression, and trauma symptoms that immediately follow exposure to trauma.

A recent study in the UK that estimated the amount of life lost from type 1 and type 2 diabetes in the country’s population found that the loss amounted to approximately 6.4 million years of future life in the current population.

Today, we’re celebrating the work of Damien Simmons, PharmD, pharmacy manager at Atlantis Pharmacy in Atlantis, Florida.

Interventions such as exercise programs and discharge planning efforts have been promising in addressing functional impairment and improving post-discharge outcomes.

Tildrakizumab is an IL-23 inhibitor indicated for adults with moderate-to-severe plaque psoriasis and is under investigation for PsA.

Of 400 dialysis patients with the Vall d’Hebron University Hospital as reference in Barcelona, Spain, 21 contracted the coronavirus disease 2019 (COVID-19) and the mortality rate in this center was 24%, according to the opening presentation at the ERA-EDTA Congress conference.

Reducing salt intake to a healthier level appears to be beneficial for the gut microbiome and blood pressure, especially in females with untreated hypertension, according to researchers at the Medical College of Georgia at Augusta University.

In this episode of OnScript with NHA, part of the Pharmacy Podcast Network, experts discuss their research on pharmacy technician workforce issues.

According to a recent study, diet can affect the outcome of chemotherapy due to microbes in the gut that can trigger changes in a patient’s response to drugs.

The investigational, marine-derived small-molecule binds to and affects the function of the protein tubulin within cells of the body.

Study shows a significant and consistent association between pregnancy loss and type 2 diabetes, which increased with more losses.

Concerningly, a majority of respondents also reported disruptions in their regular and preventative health care services.

A new study has found that hospitalized patients with COVID-19 and diabetes represent more than 20% of individuals in ICUs.

Today, we’re celebrating the work of Tony Gerlach, PharmD, a surgical intensive care unit (ICU) pharmacist at the Ohio State University Wexner Medical Center.

In the new data cut-offs from both studies, the survival advantages for the combination with fulvestrant and combination with an aromatase inhibitor were shown, but major disadvantages were also evident, according to the IQWiG.

A recent study was able to identify the region of the brain where executive functioning takes place due to the brain of a unique patient with dys-executive syndrome.

The new product is therapeutically equivalent to Pfizer’s Quelicin.

Pharmacists' No. 1 picks include DayQuil Cold & Flu and Children's Tylenol.

The COVID-19 pandemic rapidly pushed traditional face-to-face instruction within schools of pharmacy into a fully remote learning environment.